PASG (Passage Bio Corp) Net earnings per share change in current year
Passage Bio, Inc. (PASG) minimizes risks through the diversification of early-stage gene therapy research for rare pathologies. The annual EPS range reflects current dynamics, where the value of 45.50 serves as the current metric. Financial success is based on future sales of pediatric brain medications, while a flawless reputation in neurobiology ensures steady support from specialized investment funds.
Financial and market metric breakdowns for passagebio.com (PASG)
- market value and analyst target forecast:
- business market valuation indicators:
- book value of equity indicators:
- debt burden and liquidity indicators:
Debt to Equity Passage Bio, Inc.|PASG - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Passage Bio|PASG - Company Debts|Debts to Book Value Passage Bio, Inc.|PASG - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Passage Bio|Interim Coverage Ratio passagebio.com
- company profitability and valuation multiples indicators:
PASG - Company Net Income|Net Profit Forecast Passage Bio, Inc.|PASG - P/E Multiple|Projected Price to Earnings Passage Bio|PASG - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio Passage Bio, Inc.|PASG - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Passage Bio|PASG - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth passagebio.com|PASG - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Passage Bio, Inc.
Basic company analysis:PASG Passage Bio Corp
A stable workforce in the field of CNS gene therapy provides Passage Bio, Inc. (PASG) with a reliable foundation for development. The annual EPS change ratio reflects the efficiency of this structure through the percentage shift in earnings per share relative to the previous year. This positive trend confirms actual growth in the business's net income. It is critical for investors to monitor any deceleration in profit growth to minimize risks. This indicator serves as a precise signal for the timely preservation of capital.
Key competitors
Biogen Inc (BIIB) - Earnings growth in current year|NBIX (Neurocrine Biosciences Inc) - Earnings growth in current year|RGC - Net earnings per share change in current year|Earnings growth in current year AXSM|ACAD - Earnings per share growth rate in current year|Xenon - Net earnings per share growth this year|Earnings per share increase in current year VKTX|Supernus Pharma - Earnings growth in current year|CPRX: Earnings per share growth in current year|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Earnings per share growth in current year Biohaven|Earnings per share growth rate in current year Amylyx Pharmaceuticals Inc AMLX|Net earnings per share growth this year TRVI (Trevi Pharma)|PRAX (Praxis Corp) - Earnings per share increase in current year|Earnings growth in current year AVXL (Anavex Life Sciences)|Expected net earnings per share growth this year ceribell.com (CBLL)|PRTA - Earnings per share growth in current year|ALEC (Alector, Inc.) - Earnings per share growth this year|ANNX: Earnings growth in current year|Net earnings per share growth this year Omeros|Net earnings per share growth this year NGNE|acimmune.com (ACIU) - Expected net earnings per share growth this year|Earnings per share growth in current year Voyager Therapeutics, Inc. (VYGR)|NMRA: Earnings per share trend in current year|Earnings growth in current year SCLX (Scilex Holding Co.)|Earnings growth in current year Tevogen Bio Inc. TVGN|ACOG - Earnings per share growth in current year|Expected net earnings per share growth this year Cognition Therapeutics Inc. CGTX|IKT: Earnings growth in current year|Net earnings per share change in current year Cassava Sciences Inc SAVA|Earnings per share growth in current year Assertio Holdings|Earnings per share growth this year COYA (Coya)|Earnings growth in current year VTGN|OVID - Earnings per share growth rate in current year|Acumen Pharmaceuticals, Inc. - Net earnings per share growth this year|Earnings growth in current year CervoMed, Inc. CRVO|ATHE - Earnings per share growth in current year|Earnings per share increase in current year CLNN (Clene Inc.)|pepgen.com (PEPG) - Earnings per share growth in current year|Earnings per share growth rate in current year Jupiter Neurosciences, Inc. (JUNS)|Earnings per share growth in current year Relmada Therapeutics, Inc.|Annovis Bio Inc - Earnings per share trend in current year|Earnings growth in current year GRCE|Earnings growth in current year Firefly Neuro (AIFF)|Earnings per share growth in current year Klotho Neurosciences KLTO|Expected net earnings per share growth this year NeuroSense Therapeutics Ltd (NRSN)|RVPH - Earnings per share growth in current year|Expected net earnings per share growth this year MetaVia Inc MTVA|NRXS: Earnings growth in current year|Helius Medical Technologies (HSDT) - Earnings growth in current year|NEUP (Neuphoria Therapeutics, Inc.) - Earnings growth in current year|NERV - Net earnings per share change in current year|Earnings growth in current year ATHA|ADXN - Earnings per share growth rate in current year|Alzamend Neuro - Net earnings per share growth this year|Earnings per share increase in current year CYCN|Protagenic - Earnings growth in current year|KTTA: Earnings per share growth in current year|CRGT: Earnings growth in current year|ATXI - Expected net earnings per share growth this year|Earnings per share growth in current year Brainstorm Cell Therapeutics, Inc.|Earnings per share growth rate in current year Cara Therapeutics Inc CARA|Net earnings per share growth this year CHRO (Chromocell Therapeutics)|ELYM (eliemtx.com) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies, Inc.)|Expected net earnings per share growth this year Longboard Pharmaceuticals Inc (LBPH)|MRNS - Earnings per share growth in current year|NKGN (NKGen Biotech Corp) - Earnings per share growth this year|NRBO: Earnings growth in current year|Net earnings per share growth this year sagerx.com|Net earnings per share growth this year SNPX|Trevena Inc. (TRVN) - Expected net earnings per share growth this year|Earnings per share growth in current year Vigil Neuroscience (VIGL)|WENA: Earnings per share trend in current year|Earnings growth in current year CERE (Cerevel Therapeutics)
